Status
Conditions
Treatments
About
The purpose :
Detect and profile Multiple myeloma Measurable Residual Disease(MRD) prognostics for monitoring post-transplant Multiple Myeloma (MM) Patients receiving maintenance therapy.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
70 participants in 1 patient group
Loading...
Central trial contact
Rayan Kaedbey, MD FRCPC
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal